First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients
Clinical trial NCT01646450 · UNKNOWN
Trial details
- NCT number
- NCT01646450
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2015-12-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.